$2.15 B
Share price
Change (1 day)
Change (1 year)

Market capitalization of ImmunityBio (IBRX)

Market cap: $2.15 Billion

As of November 2022 ImmunityBio has a market cap of $2.15 Billion. This makes ImmunityBio the world's 3611th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ImmunityBio from 2021 to 2022

End of year Market Cap

Year Market cap Change
2022$2.15 B-10.79%
2021$2.41 B

End of Day market cap according to different sources

On Nov 25th, 2022 the market cap of ImmunityBio was reported to be:

$2.13 Billion
by Nasdaq
$2.15 Billion
by CompaniesMarketCap
$2.12 Billion
by Yahoo Finance
$2.13 Billion
by Iex Cloud

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$0.13 B-93.58%๐Ÿ‡บ๐Ÿ‡ธ USA